SCHEDULE: Norges Bank Discloses 5.38% Stake in Cabaletta Bio

Norges Bank has reported beneficial ownership of 5.38% of Cabaletta Bio, Inc.'s common stock as of June 30, 2026, classifying itself as an investment adviser.

Summary

• Norges Bank has filed a Schedule 13G, indicating it beneficially owns 8,775,653 shares of Cabaletta Bio, Inc. common stock.
• This represents 5.3820% of the class of securities.
• The filing date is June 30, 2026, and Norges Bank is identified as an investment adviser and a non-U.S. institution.
• Norges Bank holds sole voting power over 8,663,310 shares and sole dispositive power over 4,112,401 shares.
• Shared dispositive power is held over 4,663,252 shares.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, indicating a significant institutional holding without immediate implications for control or strategy changes.

Positives

• Significant institutional ownership by Norges Bank, a major sovereign wealth fund, can lend credibility and stability.
• The filing confirms Norges Bank's investment in Cabaletta Bio, suggesting a belief in the company's long-term prospects.

Negatives

• The filing does not provide specific details on the investment strategy or reasons for acquiring the stake beyond routine reporting.
• The disclosure is a standard Schedule 13G, which typically signifies passive investment rather than active engagement.

Risks

• While Norges Bank's investment is generally passive, any significant shift in its holdings could impact the stock price.
• The filing does not detail specific risks related to Cabaletta Bio's operations or market position.

Future Outlook

This filing is a disclosure of ownership and does not contain forward-looking statements or guidance from Cabaletta Bio, Inc.

Industry Context

StockSavvy.ai notes that the presence of a large, reputable institutional investor like Norges Bank in a biotechnology company like Cabaletta Bio is common, reflecting the sector's potential for growth and the need for substantial capital.

Stakeholder Impact

• Shareholders: The disclosure may be viewed positively as it indicates continued institutional interest, potentially supporting share price stability.
• Management: The filing is a routine disclosure and does not directly impact management's operational decisions, but confirms a significant investor.
• Creditors: No direct impact is indicated by this ownership filing.

Next Steps

• Norges Bank will continue to hold its shares in Cabaletta Bio, Inc. as per its investment mandate.
• Cabaletta Bio, Inc. will continue its operations and reporting as usual.

Key Dates

Keywords

Cabaletta Bio, Norges Bank, Schedule 13G, Institutional Ownership, Common Stock, Investment Adviser, Beneficial Ownership